Rough, scaly spots that don’t go away are often dismissed as “dry skin” — but in Texas, where intense UV exposure is year-round, they may be actinic keratoses: precancerous lesions that can progress to squamous cell carcinoma if left untreated. Understanding actinic keratosis versus skin cancer is critical for Central Texas patients who accumulate significant cumulative sun damage from outdoor work, recreation on the Comal and Guadalupe Rivers, and relentless Hill Country sun. Early recognition and treatment prevent cancerous transformation before it starts.
What Is Actinic Keratosis?
Actinic keratosis (also called solar keratosis) is a precancerous lesion caused by cumulative UV radiation damage to keratinocytes — the cells of the outer epidermal layer. AKs represent intraepidermal dysplasia: abnormal cellular proliferation confined to the epidermis. They are not yet invasive cancer, but they represent a step in the continuum toward squamous cell carcinoma.
AKs typically appear as:
- Small, scaly, rough patches (2–6mm) with a sandpaper-like texture
- Pink, red, tan, or brown discoloration
- Lesions on sun-exposed areas: face, ears, scalp (in bald or thinning areas), hands, forearms, neck, and décolletage
The rough, gritty texture is often the most noticeable feature — you can feel the roughness by running a finger across it. A hypertrophic AK has a thicker, more raised, wart-like appearance and carries a higher risk of progression; it should always be evaluated promptly.
The Natural History: When AK Becomes Cancer
Individual AKs have approximately a 0.1–1% annual risk of transforming into invasive squamous cell carcinoma (SCC). While this may sound modest per lesion, patients with multiple AKs — which is common in Texas — face substantially higher cumulative risk across the entire field of sun-damaged skin. A landmark patient-oriented analysis by Dodson et al. (Arch Dermatol, 1991) estimated that a patient with an average number of AKs faces roughly a 6.1–10.2% risk of developing invasive SCC over 10 years — and many Texas patients present with far more than 7–8 lesions.
The presence of multiple AKs also signals that your entire sun-exposed skin is in a “field of injury” — at elevated risk for new lesions and invasive cancers. Early treatment eliminates existing precancerous cells and removes the lesion before it can become invasive.
Squamous Cell Carcinoma: The Cancer AK Can Become
Squamous cell carcinoma (SCC) is an invasive cancer that develops when AK transforms into a lesion that invades the dermis and carries metastatic potential. SCCs typically present as:
- Firm, nodular lesions that may be scaly or crusted
- Non-healing sores or wounds
- Lesions that bleed, ooze, or are tender
- Growths that appear to arise from an existing AK
The American Academy of Dermatology describes SCC as a common skin cancer that is highly treatable when found early — but one that, left untreated, can grow deep and spread. Certain tumors carry higher risk: those on the lip or ear, those greater than 2 cm, those in immunosuppressed patients (the AAD notes the risk is highest for organ-transplant recipients), and those with perineural invasion. Delayed treatment gives the cancer time to grow, which makes treatment more difficult.
Key Differences Between AK and SCC
| Characteristic | Actinic Keratosis | Squamous Cell Carcinoma |
|---|---|---|
| Status | Precancerous (intraepidermal dysplasia) | Invasive cancer |
| Depth | Limited to epidermis | Invades dermis and beyond |
| Texture | Scaly, rough, sandpaper-like | Firm, nodular, may be ulcerated |
| Metastasis Risk | None | Low for most tumors; higher for high-risk ones (lip, ear, large, or immunosuppressed patients) |
| Treatment Urgency | Preventive; should be treated promptly | Urgent; requires prompt surgical management |
Diagnosis: How Dermatologists Distinguish Them
While clinical appearance can suggest AK versus SCC, definitive diagnosis sometimes requires a skin biopsy. Our board-certified dermatologists examine each lesion using:
- Dermoscopy (magnified imaging) to evaluate micro-morphology
- Palpation to assess depth, firmness, and induration
- Assessment of the full clinical context, including field cancerization
If there is any question about whether a lesion is AK or SCC, a punch or shave biopsy provides definitive histologic diagnosis and guides treatment. Same-day biopsies are available at Elect Dermatology.
Treatment Options for Actinic Keratosis
Early treatment of AK prevents progression to SCC. Options include:
Cryotherapy (Freezing): Liquid nitrogen applied directly to individual lesions. Quick, minimal discomfort, no anesthesia required. Lesions typically slough off within 1–3 weeks. Effective for isolated AKs; in a prospective study by Thai et al. (Int J Dermatol, 2004), cryotherapy achieved complete clearance of about 67% of treated AKs overall, rising to 83% with longer freeze times.
Topical Medications: Imiquimod (Aldara) and 5-fluorouracil (5-FU) creams treat multiple AKs simultaneously. 5-FU has been studied extensively; imiquimod stimulates immune-mediated destruction of abnormal cells. The international S3 guideline on actinic keratosis (Werner et al., JEADV 2015) recognizes both as standard field-directed therapy for patients with multiple AKs.
Photodynamic Therapy (PDT): A photosensitizing agent (aminolevulinic acid) is applied topically, then activated with blue or red light to destroy precancerous cells selectively. Particularly effective for widespread or confluent AKs across a field of sun-damaged skin. We refer patients to trusted colleagues when PDT is the best fit.
Chemical Peels: Medium-depth peels with trichloroacetic acid (TCA) treat diffuse AKs across a field of sun-damaged skin, particularly on the face and forehead.
Treatment of Squamous Cell Carcinoma
SCC requires more aggressive management than AK:
Surgical Excision: Standard excision with 4–6 mm margins for low-risk tumors, sent to pathology to confirm clear margins.
Mohs Micrographic Surgery: For larger, high-risk, recurrent, or facial SCCs, Mohs surgery provides the highest cure rates by removing thin layers of tumor with immediate microscopic margin assessment.
Curettage and Electrocautery: For very small, low-risk primary SCCs on non-critical locations.
Frequently Asked Questions
Are actinic keratoses cancer? No. AKs are precancerous lesions — they represent abnormal cellular changes confined to the epidermis that have not yet become invasive. However, they can progress to SCC if left untreated, which is why dermatologists recommend treating them.
Should AKs be removed? Yes. Treatment is recommended because it is not possible to predict which individual AKs will progress, and the treatments (especially cryotherapy) are quick and low-risk. Waiting increases cumulative progression risk.
Can AK turn into melanoma? No. AKs progress to squamous cell carcinoma — not melanoma. Melanoma arises from melanocytes (pigment cells), while AKs arise from keratinocytes. They are completely different pathways.
How fast do AKs turn into SCC? Progression is typically slow — months to years — but is unpredictable for any individual lesion. This is why “watchful waiting” is generally not recommended by most dermatologists.
Do AKs hurt? They may sting, itch, or cause a burning sensation, especially when exposed to heat or after sun exposure. Pain in a known AK may indicate progression and warrants evaluation.
Sun Protection in Texas: Prevention Is the Best Treatment
In Central Texas, year-round UV exposure, outdoor culture along the Comal River and Guadalupe River, and significant populations of ranchers, construction workers, and outdoor recreation enthusiasts make AK prevention a public health priority. The best approach:
- Broad-spectrum SPF 30+ sunscreen daily — including on cloudy days and in the car
- Protective clothing, wide-brimmed hats, UV-blocking sunglasses
- Shade during peak UV hours (10 AM–4 PM)
- Annual full-body skin checks with a board-certified dermatologist
Related Reading
For more on catching skin cancer early in Central Texas: our guide to skin cancer screening in New Braunfels explains what a screening visit involves; skin cancer risks for outdoor workers in Texas covers the occupational UV exposure that drives many AKs; and our skin cancer services page describes the full range of diagnosis and treatment options we offer.
References
- Dodson JM, et al. Malignant potential of actinic keratoses and the controversy over treatment. Arch Dermatol. 1991;127(7):1029–1031. PubMed
- Thai KE, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43(9):687–692. PubMed
- American Academy of Dermatology. Squamous cell carcinoma: from symptoms to treatments. AAD.org
- Werner RN, et al. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis. J Eur Acad Dermatol Venereol. 2015;29(11):2069–2079. PubMed
Rough, scaly patches on sun-exposed skin deserve a professional evaluation — not a wait-and-see approach. The board-certified dermatologists at Elect Dermatology in New Braunfels diagnose and treat actinic keratoses and skin cancer with cryotherapy, prescription topical therapy, and same-day biopsies when needed — and for appropriate patients who cannot undergo surgery, we offer nonsurgical superficial radiotherapy (SRT). We serve patients across New Braunfels, Seguin, San Marcos, and the broader Hill Country. Call (833) 353-2875 to schedule your full-body skin exam at 2154 Gabriels Pl, Ste 103, New Braunfels, TX 78130. Don’t let a precancerous lesion become something more.
Reviewed by Dr. Hockley
Schedule Your Dermatology Appointment
Our board certified dermatologists in New Braunfels are here to help. New patients are always welcome.
